Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

RARERARE
Showing 7 of 20 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ULTRAGENYX PHARMACEUTICAL IN

JACOBS LEVY EQUITY MANAGEMENT, INC holds 1.4M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $30M as of 2026-Q1. The position was decreased (-18.2% shares). RARE represents 0.1% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$30M

Current Shares

1.4M

Total Value Change

+$3.9M

Total Shares Change

+796,744

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.4M
-18.2%
$30M0.1%$22.07
0
2025-Q4
Decreased
1.7M
-19.3%
$40.2M0.2%$22.78
0
2025-Q3
Increased
2.2M
+614.1%
$65.2M0.3%$30.36
57
2025-Q2
New
303,565
-
$11M0.0%$36.52
38
2024-Q4
Exited
0
-100.0%
$00.0%$42.27
0
2024-Q3
Decreased
97,960
-84.6%
$5.4M0.0%$54.43
0
2024-Q2
Decreased
634,327
-7.8%
$26.1M0.1%$41.10
0

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used